Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Simon

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Blood|October 24, 2002
Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safetyFrance Noizat-Pirenne, Ketty Lee, Pierre-Yves Le Pennec, et al.
Cancer Immunology, Immunotherapy : CII|February 27, 2004
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasiaSophie Hallez, Philippe Simon, Frédéric Maudoux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2015
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast CarcinomaMarleen Keyaerts, Catarina Xavier, Johannes Heemskerk, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2024
An organic O donor for biological hydroxylation reactionsKatayoun Kazemzadeh Ferizhendi, Philippe Simon, Ludovic Pelosi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.
Neuromuscular Disorders : NMD|August 14, 2024
Defining the landscape of TIA1 and SQSTM1 digenic myopathyPaula Panos-Basterra, Julian Theuriet, Aleksandra Nadaj-Pakleza, et al.
Nature Communications|December 11, 2020
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cellsClara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Blood|October 24, 2002
Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safetyFrance Noizat-Pirenne, Ketty Lee, Pierre-Yves Le Pennec, et al.
Cancer Immunology, Immunotherapy : CII|February 27, 2004
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasiaSophie Hallez, Philippe Simon, Frédéric Maudoux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2015
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast CarcinomaMarleen Keyaerts, Catarina Xavier, Johannes Heemskerk, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2024
An organic O donor for biological hydroxylation reactionsKatayoun Kazemzadeh Ferizhendi, Philippe Simon, Ludovic Pelosi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.
Neuromuscular Disorders : NMD|August 14, 2024
Defining the landscape of TIA1 and SQSTM1 digenic myopathyPaula Panos-Basterra, Julian Theuriet, Aleksandra Nadaj-Pakleza, et al.
Nature Communications|December 11, 2020
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cellsClara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi, et al.
Pageof 9